A Phase 1b, Randomized, Double-Blind, Placebo Controlled, Single-Dose Ranging Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GS-5806 in Subjects < 24 Months of Age [...] (2013-2014)

Professor Peter Sly

NHMRC Leadership Fellow

Child Health Research Centre

Faculty of Health, Medicine and Behavioural Sciences